The case for low dose diuretic therapy

Norman M Kaplan

doi:10.1093/ajh/4.12.970

The case for low dose diuretic therapy

Norman M Kaplan

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

Diuretics remain the most popular antihypertensive agents in the US. Nonetheless, their use over the past 5 years has been falling progressively in large part because of major concerns about their multiple metabolic side effects which have been blamed for the inability to document a significant reduction in coronary disease in the multiple clinical trials wherein they have been the primary agent.1 The litany of these multiple side effects have recently been expanded by the addition of the worsening of insulin resistance.

Original language	English (US)
Pages (from-to)	970-971
Number of pages	2
Journal	American Journal of Hypertension
Volume	4
Issue number	12
DOIs	https://doi.org/10.1093/ajh/4.12.970
State	Published - Dec 1991

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1093/ajh/4.12.970

Cite this

@article{2038e21c7a4f4dddbc608db860bd5ef3,

title = "The case for low dose diuretic therapy",

abstract = "Diuretics remain the most popular antihypertensive agents in the US. Nonetheless, their use over the past 5 years has been falling progressively in large part because of major concerns about their multiple metabolic side effects which have been blamed for the inability to document a significant reduction in coronary disease in the multiple clinical trials wherein they have been the primary agent.1 The litany of these multiple side effects have recently been expanded by the addition of the worsening of insulin resistance.",

author = "Kaplan, {Norman M}",

year = "1991",

month = dec,

doi = "10.1093/ajh/4.12.970",

language = "English (US)",

volume = "4",

pages = "970--971",

journal = "American Journal of Hypertension",

issn = "0895-7061",

number = "12",

}

TY - JOUR

T1 - The case for low dose diuretic therapy

AU - Kaplan, Norman M

PY - 1991/12

Y1 - 1991/12

N2 - Diuretics remain the most popular antihypertensive agents in the US. Nonetheless, their use over the past 5 years has been falling progressively in large part because of major concerns about their multiple metabolic side effects which have been blamed for the inability to document a significant reduction in coronary disease in the multiple clinical trials wherein they have been the primary agent.1 The litany of these multiple side effects have recently been expanded by the addition of the worsening of insulin resistance.

AB - Diuretics remain the most popular antihypertensive agents in the US. Nonetheless, their use over the past 5 years has been falling progressively in large part because of major concerns about their multiple metabolic side effects which have been blamed for the inability to document a significant reduction in coronary disease in the multiple clinical trials wherein they have been the primary agent.1 The litany of these multiple side effects have recently been expanded by the addition of the worsening of insulin resistance.

UR - http://www.scopus.com/inward/record.url?scp=0026326456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026326456&partnerID=8YFLogxK

U2 - 10.1093/ajh/4.12.970

DO - 10.1093/ajh/4.12.970

M3 - Article

C2 - 1843855

AN - SCOPUS:0026326456

SN - 0895-7061

VL - 4

SP - 970

EP - 971

JO - American Journal of Hypertension

JF - American Journal of Hypertension

IS - 12

ER -

The case for low dose diuretic therapy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this